Specialty Drug Cost Trends Mirror Retail Pharmacy

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses trends in specialty drug cost management.

Related Content:

InterviewsHIVReimbursementSpecialty Pharmacy
Daily Medication Pearl: Harvoni (Ledipasvir and Sofosbuvir)
Using mRNA to Create the Elusive HIV Vaccine
Data Show High Flu Activity Early in the Season